Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis☆
Background/Aims
Increased intrahepatic resistance (IHR) in cirrhosis is due to fibrosis and hepatic endothelial dysfunction (HED). Besides producing fibrosis, increased reactive oxygen species (ROS) promotes ROS-related nitration of anti-oxidative enzymes in cirrhotic livers. Tyrosine nitration (nitrotyrosilation)-related inactivation of anti-oxidative enzymes is increased in cirrhotic livers. This study investigates effects of N-acetylcysteine (NAC) administrations in bile-duct-ligation (BDL) rats.
Methods
This study measured portal venous pressure (PVP), IHR, hepatic endothelial function, hepatic levels of anti-oxidants and oxidants, type III procollagen (PIIIP), proteins expression of thromboxane synthase (TXS), nitrotyrosine, manganese superoxide dismutase (MnSOD), and hepatic NOx and thromboxane A2 (TXA2) production in perfusates.
Results
The improvement of HED was associated with decreased PVP and IHR, hepatic protein and mRNA levels of PIIIP, protein expression of TXS and nitrotyrosine, oxidants and production of TXA2 in NAC-treated BDL rat livers. Conversely, hepatic NOx production, anti-oxidants, and protein expression of MnSOD were increased in NAC-treated BDL rat livers.
Conclusions
In NAC-treated cirrhotic rats, the decrease in IHR was mainly caused by its anti-oxidative effect-related prevention of hepatic fibrogenesis associated with the decrease of oxidants-related nitrotyrosilation and improvement of HED.
Keywords: Anti-oxidants, Intrahepatic resistance, N-Acetylcysteine, Nitrotyrosilation
Abbreviations: NAC, N-acetylcysteine, TXS, thromboxane synthase, MnSOD, manganese superoxide dismutase, TXA2, thromboxane A2, NO, nitric oxide, GSH, Glutathione, GPx, GSH peroxidase, BDL, Bile-duct-ligation
To access this article, please choose from the options below
☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the materials involved either in the past or present and they did not receive funding from the manufacturers to carry out their research.
PII: S0168-8278(08)00163-3
doi:10.1016/j.jhep.2008.02.012
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
